Engineered immune cells take on lupus in early trial
Disease control
Ongoing
This study tests a new treatment called Descartes-08 for people with systemic lupus erythematosus (SLE), an autoimmune disease. The treatment uses a patient's own immune cells that are modified in a lab to target and attack the faulty immune cells causing lupus. The main goals ar…
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 17, 2026 12:27 UTC